Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (5): 50-58.doi: 10.6040/j.issn.1671-7554.0.2022.0128

Previous Articles     Next Articles

Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics

LI Linlin, WANG Kai   

  1. Department of Hepatology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2022-06-01

Abstract: Objective To screen hepatocellular carcinoma(HCC)prognostic genes based on bioinformatics methods and explore the action mechanism of related genes. Methods The expression of NUF2 in liver cancer tissues and normal liver tissues was studied based on the TCGA-LIHC dataset, the Gene Expression Omnibus(GEO)database, and the Ualcan database. The relationship of NUF2 expression and clinicopathological features of HCC was analyzed using the Wilcoxon rank-sum test. Survival analysis, univariate analysis of prognosis, and multivariate analysis were carried out using Kaplan-Meier method and Cox proportional risk regression model, respectively. The functional mechanisms was explored based on the GO and KEGG pathway enrichment analysis. NUF2 protein interaction network was constructed using the STRING database. The NUF2 interaction genes were analyzed using the LinkedOmics database to explore the regulatory mechanism of NUF2 in hepatocarcinogenesis. In addition, the relationship between NUF2 expression and tumor-infiltrating immune cell status was investigated using the TIMER database and CIBERSORT. Results Compared to normal liver tissues, NUF2 was significantly highly expressed in HCC tissues. Multivariable Cox regression analysis identified NUF2 as an independent risk factor in HCC, and patients with high NUF2 expression had significantly shorter overall survival than those with low NUF2 expression. In addition, the NUF2 protein interaction network was constructed by the STRING database and LinkedOmics database, and the functional analysis showed that NUF2 and its associated genes were mainly involved in nuclear division, chromosome segregation, mitosis, chemical-induced carcinogenesis, cell cycle and other processes. Finally, a high proportion of resting memory CD4T cells, activated memory CD4T cells, follicular helper T cells, regulatory T cells(Treg)and M0 macrophages was observed in patients with high NUF2 expression. Conclusion Upregulation of NUF2 in HCC tissues plays a key role in HCC development. High expression of NUF2 can serve as a potential diagnostic and prognostic marker to identify early and late HCC, improve timeliness and diagnostic and prognostic accuracy. NUF2 plays a key role in the immune mechanism during HCC tumorigenesis.

Key words: NUF2, Hepatocellular carcinoma, Prognosis, Biomarkers, Tumor immunity

CLC Number: 

  • R735.7
[1] Puccini A, Battaglin F, Iaia ML, et al. Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies [J]. J Immunother Cancer, 2020, 8(1): e000404.
[2] Aizarani N, Saviano A, Sagar, et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors [J]. Nature, 2019, 572(7768): 199-204.
[3] Selcuk H. Prognostic factors and staging systems in hepatocellular carcinoma [J]. Exp Clin Transplant, 2017, 15(Suppl 2): 45-49.
[4] Grohmann M, Wiede F, Dodd GT. Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC [J]. Cell, 2018, 175(5): 1289-1306 e20.
[5] Petrick JL, Kelly SP, Altekruse SF, et al. Future of hepatocellular carcinoma incidence in the United States forecast through 2030 [J]. J Clin Oncol, 2016, 34(15): 1787-1794.
[6] Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data [J]. Bioinformatics, 2010, 26(1): 139-140.
[7] Gene Ontology Consortium. The Gene Ontology(GO)project in 2006 [J]. Nucleic Acids Res, 2006, 34(Database issue): D322-D326.
[8] Du J, Yuan Z, Ma Z, et al. KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model [J]. Mol Biosyst, 2014, 10(9): 2441-2447.
[9] Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles [J]. Nat Methods, 2015, 12(5): 453-457.
[10] Shah P, Wolf K, Lammerding J. Bursting the bubble-nuclear envelope rupture as a path to genomic instability? [J]. Trends Cell Biol, 2017, 27(8): 546-555.
[11] Ohnuma S, Miura K, Horii A, et al. Cancer-associated splicing variants of the CDCA1 and MSMB genes expressed in cancer cell lines and surgically resected gastric cancer tissues [J]. Surgery, 2009, 145(1): 57-68.
[12] Kaneko N, Miura K, Gu Z, et al. siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis [J]. Biochem Biophys Res Commun, 2009, 390(4): 1235-1240.
[13] Hayama S, Daigo Y, Kato T, et al. Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis [J]. Cancer Res, 2006, 66(21): 10339-10348.
[14] Kobayashi Y, Takano A, Miyagi Y, et al. Cell division cycle-associated protein 1 overexpression is essential for the malignant potential of colorectal cancers [J]. Int J Oncol, 2014, 44(1): 69-77.
[15] Bajar BT, Lam AJ, Badiee RK, et al. Fluorescent indicators for simultaneous reporting of all four cell cycle phases [J]. Nat Methods, 2016, 13(12): 993-996.
[16] Wang Y, Tan PY, Handoko YA, et al. NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection [J]. Int J Cancer, 2019, 145(3): 662-670.
[17] Coppell JA, Richardson PG, Soiffer R, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome [J]. Biol Blood Marrow Transplant, 2010, 16(2): 157-168.
[18] Yang WX, Pan YY, You CG. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 may be potential therapeutic targets for hepatocellular carcinoma using integrated bioinformatic analysis [J]. Biomed Res Int, 2019, 2019: 1245072.
[19] Liu X, He Y, Li F, et al. Caspase-3 promotes genetic instability and carcinogenesis [J]. Mol Cell, 2015, 58(2): 284-296.
[20] Hamalisto S, Stahl JL, Favaro E, et al. Spatially and temporally defined lysosomal leakage facilitates mitotic chromosome segregation [J]. Nat Commun, 2020, 11(1): 229.
[21] Zhang T, Zhou Y, Qi ST, et al. Nuf2 is required for chromosome segregation during mouse oocyte meiotic maturation [J]. Cell Cycle, 2015, 14(16): 2701-2710.
[22] Mao Y. FORMIN a link between kinetochores and microtubule ends [J]. Trends Cell Biol, 2011, 21(11): 625-629.
[23] Xie X, Jiang S, Li X. Nuf2 is a prognostic-related biomarker and correlated with immune infiltrates in hepatocellular carcinoma [J]. Front Oncol, 2021, 11: 621373. doi: 10.3389/fonc.2021.621373.
[24] Lampel J, Shapira Z. Judgmental errors,interactive norms, and the difficulty of detecting strategic surprises [J]. Organ Sci, 2001, 12(5): 599-611.
[25] Numnum TM, Makhija S, Lu B, et al. Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines [J]. Gynecol Oncol, 2008, 108(1): 34-41.
[26] Harao M, Hirata S, Irie A, et al. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL [J]. Int J Cancer, 2008, 123(11): 2616-2625.
[27] Duffy AG, Makarova-Rusher OV, Greten TF. The case for immune-based approaches in biliary tract carcinoma [J]. Hepatology, 2016, 64(5): 1785-1791.
[28] Obara W, Sato F, Takeda K, et al. Phase I clinical trial of cell division associated 1(CDCA1)peptide vaccination for castration resistant prostate cancer [J]. Cancer Sci, 2017, 108(7): 1452-1457.
[29] Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome [J]. Science, 2006, 313(5795): 1960-1964.
[1] YU De-Xin, CAEI Ti-Gong, MA Xiang-Xing, ZHANG Xiao-Ming, LI Chuan-Fu. Angiogenesis and maturation of hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 51-54.
[2] LI Ziqi, WEI Yanruoxue, LIU Xiaohan, LIU Chuncheng, ZHAO Ran, LIU Yukun. The functional role and clinical significance of lncRNA HEATR3-AS1 in colorectal cancer tumorigenesis and progression [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 108-115.
[3] XUE Fuzhong. Theoretical and methodological framework for multimodal big data cohort design based on AI language representation [J]. Journal of Shandong University (Health Sciences), 2025, 63(8): 1-16.
[4] LIU Baoguo, SONG Xiang, ZHAO Xiaowen, MAO Yali. Application value of serum STAT5B and NKAIN1 mRNA detection in breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 68-74.
[5] WANG Lei, CHANG Xiao, WANG Zimeng, LI Jiaojiao, CUI Shujun, YANG Fei, ZHU Yuexiang. Predictive value of intratumoral and peritumoral DCE-MRI imaging histology for progression-free survival in patients with cervical cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 45-54.
[6] JIA Ruoxi, LYU Li, LIU Hanyun, WU Yinping, LI Fengcai, ZHAO Zehua, WANG Kai, FAN Yuchen. Diagnostic value of blood cell count-related biomarkers in predicting 28-day mortality in acute-on-chronic hepatitis b liver failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 89-99.
[7] ZHAO Hanqing, ZHOU Xinrui, LI Zijian, TANG Xing. Application of circulating tumor cells combined with serological detection in non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 79-85.
[8] DU Xue, LI Chunxia, LIU Yunxia, ZHANG Tao. Dynamic prediction model for the colorectal cancer patients prognosis based on MFPC-Cox [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 101-110.
[9] YANG Weifang, XU Hong, LIU Yuantao, ZHAO Huichen. Mechanism of thyroid-stimulating immunoglobulin in Graves disease recurrence and clinical significance [J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 116-121.
[10] GONG Jie, YU Miao, LI Xiuyong, CHEN Ying, XU Qianru, LI Meijuan, LI Yitong, LIU Xiumei. Construction of polysaccharide probe based on upconversion nanoparticles and its application in tumor bioimaging [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 18-26.
[11] LIU Wenzhao, ZHANG Yuan, MA Xiangping, WEI Fengtao, BU Peili. Correlation between the pre-endothelial activation and stress index and the mortality risk of patients with heart failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 27-35.
[12] CHEN Wenliang, WANG Huanhuan, HAO Jinjin, GONG Rui, ZHAO Qiang, ZHANG Fei, GAO Lei, DONG Jingxun. The role of lncRNA PVT1 in prognostic assessment and malignant progression of gastric cancer: a study based on nomogram model and functional cellular experiments [J]. Journal of Shandong University (Health Sciences), 2025, 63(10): 61-71.
[13] WANG Jing, LIU Xiaofei, ZENG Rong, XU Changjuan, ZHANG Jintao, DONG Liang. Identification of necroptosis-related biomarkers in asthma based on machine learning algorithms [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 21-32.
[14] GUO Shuhua, FAN Yang, TIAN Feng, WANG Chuanxin, DU Lutao, LI Peilong, GUO Xing, XU Shuo. Role of microfibril-associated protein 3 in regulating mesenchymal transition of glioma stem cells [J]. Journal of Shandong University (Health Sciences), 2024, 62(6): 9-16.
[15] SHI Shuochuan, ZENG Rong, ZHANG Jintao, ZHANG Dong, PAN Yun, LIU Xiaofei, XU Changjuan, WANG Ying, DONG Liang. Bioinformatics-based exploration of potential differential immune genes and immune infiltration signatures in bronchial asthma [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 43-53.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!